Pruritus at the site of active acne has not been described before as a
complication of acne therapy. We report 8 cases seen over a 3-year pe
riod at our department with localized itching mainly at the active acn
e sites, within 2-6 weeks of starting effective acne therapy. Seven ha
d oral tetracyclines (oxytetracycline, Vibramycin or Minocin) with or
without topical antibiotics or benzoyl peroxide. Only 1 patient receiv
ed oral isotretinoin. The severity of itch was mild to moderate in mos
t cases with the severest reaction in the isotretinoin-treated patient
. All cases resolved within 4 weeks, 7 with non-sedative antihistamine
therapy (terfenadine), and 1 resolved spontaneously upon cessation of
antibiotic therapy. The pathogenesis of this localized itch is presum
ed to be related to the change in pH of the micro-environment of the a
cne follicle providing an optimal environment for the production of hi
stamine or histamine-like products by Propionibacterium acnes. This re
port highlights the self-limiting nature of pruritus during effective
anti-acne therapy. Increased awareness of this uncommon complication h
elps prevent the unnecessary discontinuation of effective acne therapy
.